BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36750252)

  • 1. Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis.
    DiVita Dean B; Wildes T; Dean J; Yegorov O; Yang C; Shin D; Francis C; Figg JW; Sebastian M; Font LF; Jin D; Reid A; Moore G; Fernandez B; Wummer B; Kuizon C; Mitchell D; Flores CT
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
    Wildes TJ; Grippin A; Dyson KA; Wummer BM; Damiani DJ; Abraham RS; Flores CT; Mitchell DA
    Clin Cancer Res; 2018 Aug; 24(16):3955-3966. PubMed ID: 29712687
    [No Abstract]   [Full Text] [Related]  

  • 3. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
    Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
    Front Immunol; 2020; 11():573406. PubMed ID: 33193358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of early myeloid progenitors as immunosuppressive cells.
    Pu S; Qin B; He H; Zhan J; Wu Q; Zhang X; Yang L; Qu C; Zhou Z
    Sci Rep; 2016 Mar; 6():23115. PubMed ID: 26979287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas.
    Wildes TJ; Dyson KA; Francis C; Wummer B; Yang C; Yegorov O; Shin D; Grippin A; Dean BD; Abraham R; Pham C; Moore G; Kuizon C; Mitchell DA; Flores CT
    Clin Cancer Res; 2020 Nov; 26(21):5689-5700. PubMed ID: 32788225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
    Wu WC; Sun HW; Chen HT; Liang J; Yu XJ; Wu C; Wang Z; Zheng L
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4221-6. PubMed ID: 24591638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.
    Thaci B; Ahmed AU; Ulasov IV; Wainwright DA; Nigam P; Auffinger B; Tobias AL; Han Y; Zhang L; Moon KS; Lesniak MS
    Cancer Gene Ther; 2014 Jan; 21(1):38-44. PubMed ID: 24434573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells.
    Magidey-Klein K; Cooper TJ; Kveler K; Normand R; Zhang T; Timaner M; Raviv Z; James BP; Gazit R; Ronai ZA; Shen-Orr S; Shaked Y
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34140316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
    Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
    Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment.
    Sceneay J; Griessinger CM; Hoffmann SHL; Wen SW; Wong CSF; Krumeich S; Kneilling M; Pichler BJ; Möller A
    PLoS One; 2018; 13(4):e0196040. PubMed ID: 29677215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells in gliomas.
    Gieryng A; Kaminska B
    Contemp Oncol (Pozn); 2016; 20(5):345-351. PubMed ID: 28373814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.
    Kohanbash G; Okada H
    Immunol Invest; 2012; 41(6-7):658-79. PubMed ID: 23017140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
    Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche.
    Giles AJ; Reid CM; Evans JD; Murgai M; Vicioso Y; Highfill SL; Kasai M; Vahdat L; Mackall CL; Lyden D; Wexler L; Kaplan RN
    Cancer Res; 2016 Mar; 76(6):1335-47. PubMed ID: 26719537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor.
    Zilio S; Bicciato S; Weed D; Serafini P
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
    Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
    Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.